HUVEC were seeded onto glass coverslips and treated with CPA as described above. Eight days after CPA-treatment, the cells were fixed in 4% paraformaldehyde in
PBS (Morphisto GmbH, Offenbach am Main, Germany) for 10 min, permeabilized in 0.25%
Triton X-100 (Carl Roth GmbH+Co. KG, Karlsruhe, Germany) for 3 min and blocked in 1 × phosphate-buffered saline (
PBS, Bio&Sell GmbH, Feucht, Germany) with 3%
bovine serum albumin (BSA, Carl Roth GmbH) for 30 min. Thereafter, cells were first incubated with anti-phospho-histone H2AX mouse monoclonal IgG (Merck Millipore) diluted 1:1000 in 1 ×
PBS/1% BSA for 1 h at room temperature. Then the cells were incubated with polyclonal
Cy3-conjugated goat-anti-mouse antibody (Jackson Immuno Research Laboratories, Inc., West Grove, PA, USA) and 0.2 μg/mL
DAPI (Carl Roth GmbH) diluted in 1 ×
PBS/1% BSA for 1 h at room temperature. Immunofluorescence images were obtained with a
ZEISS LSM 800 (Carl Zeiss, Jena, Germany). The cell nuclei as well as γH2AX foci were counted using the bioimage analysis software QuPath.
Krüger-Genge A., Köhler S., Laube M., Haileka V., Lemm S., Majchrzak K., Kammerer S., Schulz C., Storsberg J., Pietzsch J., Küpper J.H, & Jung F. (2023). Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis. Cells, 12(15), 1965.